FDAnews
www.fdanews.com/articles/131451-ariad-pharma-sets-sights-on-two-marketed-cancer-drugs

Ariad Pharma Sets Sights on Two Marketed Cancer Drugs

October 28, 2010
Like Millennium has done with its game-changing cancer treatment bortezomib (Velcade), Ariad now has a big opportunity with the lead cancer drug in its pipeline, ridaforolimus.
Xconomy